Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;470(5):1436-41.
doi: 10.1007/s11999-012-2306-7. Epub 2012 Mar 9.

Perioperative clopidogrel and postoperative events after hip and knee arthroplasties

Sumon Nandi  1 , Mehran Aghazadeh, Carl Talmo, Claire Robbins, James Bono
Affiliations

Perioperative clopidogrel and postoperative events after hip and knee arthroplasties

Sumon Nandi et al. Clin Orthop Relat Res. 2012 May.

Abstract

Background: Hip and knee arthroplasties are widely performed and vascular disease among patients having these procedures is common. Clopidogrel is a platelet inhibitor that decreases the likelihood of thrombosis. It may cause intraoperative and postoperative bleeding, but its discontinuation increases the risk of vascular events. There is currently no consensus regarding the best perioperative clopidogrel regimen that balances these concerns.

Questions/purposes: We determined (1) the relationship between time of perioperative clopidogrel administration and postoperative bleeding-related events after hip and knee arthroplasties and (2) patient characteristics or surgical factors that may predict these events.

Methods: We retrospectively queried our inpatient pharmacy database for patients who received clopidogrel from 2007 to 2009 and identified 116 patients who underwent hip or knee arthroplasty. We recorded the time of perioperative clopidogrel administration, bleeding-related postoperative events, patient characteristics, and surgical factors.

Results: Patients who withheld clopidogrel 5 or more days before hip or knee arthroplasty had lower rates of reoperation for infection and antibiotics prescribed for the surgical wound. Postoperative events did not vary with timing of clopidogrel resumption after surgery. Advanced age, an American Society of Anesthesiologists (ASA) score of 4, and revision surgery predicted increased readmission, reoperation for hematoma or infection, antibiotic use, and death.

Conclusions: Holding clopidogrel for at least 5 days before hip or knee arthroplasty may lower the rate of bleeding-related events. We found no increase in events when patients resumed clopidogrel immediately after surgery. Advanced age, ASA score of 4, and revision surgery may be risk factors for bleeding-related events.

Level of evidence: Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership (August 2010). PLAVIX (clopidogrel bisulfate): help prevent clot formation for heart attack, stroke, or PAD patients. PLAVIX (clopidogrel bisulfate) tablets prescribing information. Available at: www.plavix.com. Accessed October 15, 2010.
    1. Butler MJ, Eccleston D, Clark DJ, Ajani AE, Andrianopoulos N, Brennan A, New G, Black A, Szto G, Reid CM, Yan BP, Shaw JA, Dart AM. Melbourne Interventional Group. The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents. Am Heart J. 2009;157:899–907. doi: 10.1016/j.ahj.2009.02.018. - DOI - PubMed
    1. Dorr LD, Gendelman V, Maheshwari AV, Boutary M, Wan Z, Long WT. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment. J Bone Joint Surg Am. 2007;89:2648–2657. doi: 10.2106/JBJS.F.00235. - DOI - PubMed
    1. Dripps RD. New classification of physical status. Anesthesiology. 1963;24:111.
    1. Harty JA, McKenna P, Moloney D, D’Souza L, Masterson E. Anti-platelet agents and surgical delay in elderly patients with hip fractures. J Orthop Surg (Hong Kong). 2007;15:270–272. - PubMed

MeSH terms